ARG1 and neoplasm: As shown in Fig. 2f, tumour-derived mMDSCs showed higher levels of T-cell suppression in vitro that may be due to higher levels of nitric oxide synthase (NOS2) and arginase 1 (ARG1; Fig. 2g,h).